How Big Pharma Fools Even Your Doctor

November 27th, 2011 | Posted by Fred Bloem, MD in Health Policies

From Mercola.com – November 26, 2011

One of the more flagrant offenses committed by pharmaceutical companies and the medical profession is the practice of “ghostwriting” medical articles.

A new cross-sectional survey found that more than 20 percent of articles published in six leading medical journals during 2008 were likely written by honorary- and/or ghost writers.

This is lower than it was in 1996, but still far too common for comfort.

For medical journals, ghostwriting usually refers to writers sponsored by a drug or medical device company, who make major but uncredited research- or writing contributions.

The articles are instead published under the names of academic authors.

Such “inappropriate authorship” leads to a lack of transparency and accountability, which has become an important concern for the academic community.

Click here to read the rest of the story.

 

You can follow any responses to this entry through the RSS 2.0 You can skip to the end and leave a response. Pinging is currently not allowed.

Leave a Reply

Your email address will not be published. Required fields are marked *